Arash Nayeri, MD, MS
Preventive Cardiologist, GLP-1 Researcher
Dr. Arash Nayeri (MD, MS, FACC, FASE) is a board-certified cardiologist at Cedars-Sinai's Smidt Heart Institute and partner at COR Medical Group, where he practices preventive and longevity cardiology. Vanderbilt- and UCLA-trained and board-certified in cardiovascular disease, echocardiography, and nuclear cardiology, he has authored 30+ peer-reviewed papers, including a JACC state-of-the-art review and senior-authored research on how far physician and patient beliefs about GLP-1 drugs drift from the trial evidence. He collaborates with HeartFlow on AI plaque analysis and teaches physicians nationally on AI-enabled cardiac imaging. A Castle Connolly and Super Doctors Rising Star, and a Los Angeles Magazine Top Doctor. Explore GLP-1 and cardiometabolic risk, coronary CT with AI plaque quantification, cholesterol strategy, heart failure, valvular disease, cardio-oncology, and women's cardiovascular health, including his research on diastolic dysfunction in perimenopausal women.
Clear, Quantitative Insights: Gain precise, evidence-based understanding of cardiovascular risks and treatments, transforming vague worries into actionable knowledge.
Proactive Health Strategy: Leverage advanced imaging and research-backed methods to detect and address heart disease early, before symptoms disrupt your life.
Empowered Medical Decisions: Make confident, informed choices about your heart health, guided by a clinician-researcher dedicated to scientific accuracy and patient agency.
Dr. Arash Nayeri is driven by a profound belief that heart disease doesn't have to announce itself with symptoms. He champions proactive, evidence-based prevention, convinced that precise data and advanced imaging can reveal risks long before they become critical. He sees a crucial role in closing the gap between scientific evidence and public perception, empowering individuals with accurate numbers to foster true patient agency in their health decisions. His philosophy emphasizes that knowing your real, quantifiable risk is the first step toward a longer, healthier life, especially for often-overlooked populations like perimenopausal women.
Dr. Nayeri is a leading cardiologist renowned for his dual expertise as a clinician-researcher. Board-certified in multiple cardiovascular specialties, he spearheads innovative research into GLP-1s and AI-enabled cardiac imaging, actively shaping the future of preventive care. His unique ability to bridge cutting-edge science with patient-centered practice means he translates complex data into clear, actionable strategies, whether optimizing lipid management, addressing women's cardiovascular health, or guiding decisions about advanced diagnostic tests. He equips patients to confront cardiovascular risk with confidence and precision, leveraging his profound knowledge to foster long-term heart health.
- Board Certified, Cardiovascular Disease
- Board Certified, Echocardiography
- Board Certified, Nuclear Cardiology
- Fellow of the American College of Cardiology (FACC)
- Fellow of the American Society of Echocardiography (FASE)
- MD, Vanderbilt University School of Medicine (2016)
- BA, Molecular and Cell Biology, University of California, Berkeley
This onix was curated by the expert. Their knowledge, their methodology, their voice.